Moffitt logo

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More

Clinical Trials Search

Clinical Trial 20859

Cancer Type: Thoracic
Study Type: Treatment
NCT#:

Phase: Phase II
Prinicipal Investigator: Andreas Saltos

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects with Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)

Summary

Objective

Treatments

Therapies

Medications

Patritumab Deruxtecan ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

;